Fanny Jaulin, PhD, is the CEO and Cofounder of Orakl Oncology, a company dedicated to building real-world solutions to bring more drugs to cancer patients. Her journey from academia to entrepreneurship is driven by a vision for a future shaped by science and bold ideas, aiming for significant societal impact in health.

Prior to cofounding Orakl Oncology, Dr. Jaulin held prominent research positions.